Clinical Trials Logo

Clinical Trial Summary

This study will assess the effect of severe kidney impairment on the pharmacokinetics (PK), safety and tolerability of Leritrelvir.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06160622
Study type Interventional
Source Guangdong Raynovent Biotech Co., Ltd
Contact
Status Completed
Phase Phase 1
Start date September 26, 2023
Completion date December 12, 2023

See also
  Status Clinical Trial Phase
Completed NCT04308642 - Study to Evaluate Blood and Urine Kidney Injury Markers to Facilitate Early Detection of Renal Adverse Drug Events in Pediatric Cancer Patients Treated With Nephrotoxic Chemotherapy
Recruiting NCT06248567 - Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease Phase 1